Study of a Shortened Radiation Therapy Schedule in People With Breast

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT03595592` - Neoadjuvant Treatment of HER2 Positive Early High-risk and Locally Advanced Breast Cancer	Phase 3
Recruiting	`NCT05383196` - Onvansertib + Paclitaxel In TNBC	Phase 1/Phase 2
Recruiting	`NCT06158217` - Effect of Ultrasound Combined With Microbubbles on Blood Perfusion in Invasive Breast Cancer
Active, not recruiting	`NCT04448886` - Sacituzumab Govitecan +/- Pembrolizumab In HR+ / HER2 - MBC	Phase 2
Completed	`NCT02773784` - Comparison of CNB and Surgical Specimens for ER, PgR, HER2 Status and Ki67 Index in Invasive Breast Cancer.
Recruiting	`NCT01509781` - Suction Drain Versus the Use of Adaptive Skin Sutures After Mastectomy ± Axillary Lymphadenectomy; a Prospective Randomised Study	Phase 3
Completed	`NCT04478669` - Digital Breast Tomosynthesis (DBT) to Improve Assessment of Resection Margins in Invasive Breast Cancer
Recruiting	`NCT04553770` - Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer	Phase 2
Recruiting	`NCT04677816` - Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients	Phase 2
Terminated	`NCT01934335` - Effect of Vandetanib on Cellular Markers in Invasive Breast Cancer	Phase 2
Completed	`NCT00507611` - Axillary Lymph Node Status After Completion of Preoperative Neoadjuvant Systemic Chemotherapy in Patients	N/A
Completed	`NCT00581750` - Molecular Genetic Basis of Invasive Breast Cancer Risk Associated With Lobular Carcinoma in Situ
Completed	`NCT03304171` - Overall Diet Quality and Breast Cancer Risk	N/A
Completed	`NCT03709186` - Radiomic Markers for Breast Cancer Metastasis and Treatment Response Using MRI
Terminated	`NCT03361800` - Window of Opportunity Trial of Entinostat in Patients With Newly Diagnosed Stage I-IIIC,TNBC	Early Phase 1
Recruiting	`NCT06328465` - fREEDOM: REsonance for Early Detection Of Breast Cancer Metastases	N/A
Active, not recruiting	`NCT03109522` - Axillary Reverse Mapping (ARM) Technique	N/A
Recruiting	`NCT03987555` - Paclitaxel Therapeutic Drug Monitoring in Cancer Patients
Recruiting	`NCT03497702` - Neo-adjuvant Chemotherapy With Letrozole in Patients With Estrogen Receptor Positive/HER-2 Negative Breast Cancer	Phase 2
Recruiting	`NCT05795101` - TRUDI: TDXD+Durva in HER2+/Low IBC	Phase 2

NCT number	NCT04648904
Study type	Interventional
Source	Memorial Sloan Kettering Cancer Center
Contact	Aftif Khan, MD
Phone	848-225-6334
Email	khana7@mskcc.org
Status	Recruiting
Phase	Early Phase 1
Start date	November 24, 2020
Completion date	November 2024

Study of a Shortened Radiation Therapy Schedule in People With Breast Cancer

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms